Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: TMT
In recent quarters mVISE has completed the acquisition of a consulting team from SHS Viveon and the sale of loss-making workforce management software business Just Intelligence (JI). These have increased mVise’s ability to derive synergies from within the group and its focus on its core business of digitisation transformation. In H118, helped by increased consulting rates, the group was also able to report a 78% y-o-y increase in revenue and 50% margin expansion leading to a 1.6x y-o-y increase in EBITDA. We see good grounds for a continuation of favourable results in H2. Currently, mVise shares trade at a 24% discount to its two most profitable consulting-oriented peers on FY2 EV/EBITDA multiples. We believe this shows strong upside potential given the group’s growing exposure to the much more highly rated software products segment.
Written by
mVise |
Focus on digital transformation and synergies
Software and comp services |
Scale research report - Update
18 September 2018 |
Share price graph
Share details
Business description
Bull
Bear
Analyst
|
||||||||||||||||||||||||||
In recent quarters mVISE has completed the acquisition of a consulting team from SHS Viveon and the sale of loss-making workforce management software business Just Intelligence (JI). These have increased mVise’s ability to derive synergies from within the group and its focus on its core business of digitisation transformation. In H118, helped by increased consulting rates, the group was also able to report a 78% y-o-y increase in revenue and 50% margin expansion leading to a 1.6x y-o-y increase in EBITDA. We see good grounds for a continuation of favourable results in H2. Currently, mVise shares trade at a 24% discount to its two most profitable consulting-oriented peers on FY2 EV/EBITDA multiples. We believe this shows strong upside potential given the group’s growing exposure to the much more highly rated software products segment.
JI sale increases digitalisation focus and synergies
Exiting from the 78% stake in JI was a strategic step that has taken mVise out of the loss-making workforce management software business. This is a positive development as JI had low synergies with the rest of the business and diverted management time from the group’s strategic aims. As JI was loss making, the sale at end July should have an immediate positive impact on earnings.
Improved outlook for second half
We are positive on the outlook for seasonally strong and therefore important H2 earnings. We expect earnings to benefit from the sale of JI, reduced costs from integrating the SHS Viveon team, increasing sales traction at integration platform elastic.io, and the addition of new product features at SalesSphere. After a €4.6m increase in net financial debt to €8.6m in H1 following payment for the SHS Viveon acquisition and low seasonal H1 cash generation we see good prospects for a material drop in net debt helped by the deconsolidation of Just Intelligence.
Valuation: Good 12-month catalysts for rerating
On current prospective 2019 EV/EBITDA multiple of 8.9x, mVise trades at a 24% discount to the average of its most profitable consulting-oriented peers, Capgemini and Addesso. We see a strong case for the stock trading at a premium to the consulting sector reflecting its exposure to the higher-rated software product sector and the synergy benefits of its exposure to both areas. Likely strong H2 results, sales expansion at elastic.io and falling group net debt are likely share catalysts.
|
Consensus estimates
Source: mVISE, SMC Research |
Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.
H118 results: Record post-IPO operating result
Helped by the addition of consulting revenues from the acquisition of SHS Viveon, H118 revenues grew 73% y-o-y to €9.2m and outflanked employee cost growth of 61%. The result was a reduction in the employee share of revenues from 63% of H117 to 59%. Helped by this and similar operational gearing-led improvements in material cost ratios, the EBITDA margin expanded from 4.8% in H117 to 7.2%, enabling group EBITDA to grow 161% y-o-y to €0.66m.
Key factors in the strong EBITDA performance were:
■
Increases in day rates in the consulting business arising from high levels of capacity utilisation, helped by the acquisition of SHS Viveon in Southern Germany in late February with the addition of 40 new advisers. Other factors in consulting were strong growth in new customer numbers and demand for managed services.
■
Intense marketing of and the addition of new features to SalesSphere, the digital sales platform, which led to increased downloads and expressions of interest in the product.
■
A major client win (unnamed) for the integration platform elastic.io, arising from the partnership with Israeli software vendor, Magic Software.
Exhibit 1: mVise interim results summary
€m |
H117 |
H118 |
Chg |
H217 |
Year end 31 December |
HGB |
HGB |
% y-o-y |
HGB |
Income statement |
||||
Revenue |
5.34 |
9.23 |
72.8 |
9.44 |
Employee costs |
(2.67) |
(4.31) |
61.2 |
(3.35) |
Material costs |
(1.03) |
(2.62) |
155.2 |
(1.92) |
EBITDA |
0.25 |
0.66 |
161.0 |
1.70 |
EBITDA margin |
4.8% |
7.2% |
|
18.0% |
EBIT |
(0.53) |
0.04 |
(107.0) |
1.07 |
EBIT margin |
(9.9%) |
0.4% |
|
11.4% |
Profit before tax (as reported) |
(0.64) |
(0.15) |
(77.2) |
0.95 |
Net income after minorities (as reported) |
0.12 |
(0.11) |
(189.6) |
1.19 |
EPS (as reported) (€) |
0.02 |
(0.01) |
(131.0) |
0.13 |
Cash flow |
|
|
|
|
Net cash from ops before WC movements |
0.25 |
0.63 |
150.8 |
(0.25) |
Net cash from operating activities |
(0.55) |
(0.06) |
(88.8) |
0.65 |
Net cash from investing activities |
(2.88) |
(4.10) |
42.7 |
(0.87) |
Net cash from financing activities |
3.32 |
1.72 |
(48.2) |
2.58 |
Net cash flow |
(0.11) |
(2.45) |
2,186.9 |
2.35 |
Net cash (debt)* |
(3.75) |
(8.61) |
129.8 |
(3.98) |
Source: Company, Edison Investment Research. Note: *Net debt excludes ‘other liabilities’, which at end-2017 totalled €3.67m and included the obligation to pay SHS Viveon €3.2m for the consulting team acquisition.
Cash flow/balance sheet
Cash flow from operations before working capital changes increased from €252k in H117 to €632k in H118 helped by the growth in operating profit during the period. Total investment outflows were boosted by the acquisition of SHS Viveon, which gave rise to a €3.2m cash outflow on asset acquisitions, boosting overall investment outflows to €4.1m from €2.9m. Investment in plant and equipment remained flat in both periods at around €0.9m.
Group net debt increased by €4.6m to €8.6m in the first half of the year, principally due to the payment of €3.2m to SHS Viveon for the consulting team acquisition, which had been included in other liabilities in the balance sheet at the end of 2017. We expect net debt levels to fall during H218 with sale of JI, reflecting both the removal of its debt from the consolidated balance sheet on 31 July and the addition of proceeds from the sale (the magnitude of both its debt and the proceeds of the sale are not yet reported).
Outlook
The group was able to report a more than doubling in order backlog to over €7m over the June 30 level of €3.1m. The bulk of the backlog arose in the professional services side, reflecting the addition of SHS Viveon’s backlog, while the product area backlog totalled a lower €0.6m.
Management anticipates that the order backlog will be boosted in favour of the product portfolio this year, reflecting anticipated growth in demand for the sales digitalisation platform SalesSphere and elastic.io products.
The sale of JI will result in deconsolidation of its results from end July 2018. We understand that it made losses at the EBITDA and net levels in H1, with the net loss reported as €31,000. As a result, the sale of the business should be positive for H2 results and should have a positive impact on net debt balances. The agreement to keep the sale price confidential means the impact on the balance sheet is not yet quantifiable, but we understand the stake was sold with all the existing debt remaining in the company.
With the increase in demand evident in H118, management plans to recruit more consulting staff to replace the use of consultants, which should help reduce the share of revenue taken by employee expenses.
Valuation
mVise does not fit neatly into a single peer group. Its consulting operations have similarities with consulting-oriented firms such as Capgemini and Addesso while its product sales give it similarities to the software developer segment. The latter trades at substantially higher multiples than the consulting sector as can be seen in Exhibit 2.
Exhibit 2: mVise valuation table
Price* |
Market cap |
Sales |
EBITDA margin |
EV/Sales |
EV/ EBITDA |
P/E |
Div yield |
||||
Name |
|
m ($) |
FY1 (m) |
FY1 (%) |
1FY (x) |
FY2 (x) |
FY1 (x) |
FY2 (x) |
FY1 (x) |
FY2 (x) |
last (x) |
mVise |
4.32 |
42.5 |
24 |
15.6 |
1.9 |
1.5 |
11.9 |
8.8 |
29.4 |
14.9 |
0.0 |
Peers consulting orientation |
|
|
|
||||||||
SHS Viveon |
4.0 |
10 |
N/A |
0.0 |
0.6 |
0.5 |
N/A |
17.5 |
neg. |
133.3 |
0.0 |
Adesso |
65.4 |
474 |
359 |
8.1 |
1.1 |
1.0 |
14.1 |
12.9 |
26.7 |
24.1 |
0.6 |
Capgemini |
107.7 |
21,170 |
13,098 |
14.2 |
1.6 |
1.5 |
11.0 |
10.1 |
17.9 |
16.1 |
1.6 |
Consulting peer median |
|
|
6,729 |
8.1 |
1.1 |
1.0 |
12.5 |
12.2 |
22.3 |
24.1 |
0.6 |
Peers product orientation |
|
|
|
|
|
|
|
|
|
|
|
Magic Software Enterprises |
9.0 |
439 |
288 |
N/A |
1.4 |
1.3 |
N/A |
N/A |
15.2 |
10.5 |
2.4 |
Atlassian Corp - Class A |
90.5 |
21,369 |
1,157 |
26.7 |
18.4 |
14.6 |
69.1 |
52.8 |
122.5 |
99.6 |
0.0 |
Invision AG |
17.4 |
46 |
14 |
8.1 |
2.6 |
2.3 |
32.0 |
19.6 |
124.4 |
46.7 |
0.0 |
Product peer median |
|
|
350 |
8.1 |
8.3 |
6.4 |
50.6 |
52.8 |
122.5 |
46.7 |
0.0 |
All peer median |
|
|
359 |
8.1 |
1.5 |
1.4 |
13.3 |
12.9 |
26.7 |
22.7 |
0.3 |
mVISE premium to consulting median |
|
|
62.2 |
48.1 |
(5.2) |
(27.5) |
31.6 |
(38.2) |
(100.0) |
||
mVISE premium to product median |
|
|
(77.5) |
(75.9) |
(76.5) |
(83.2) |
(76.0) |
(68.1) |
N/A |
||
mVISE premium to median |
|
|
|
|
24.1 |
10.0 |
(10.7) |
(31.6) |
9.9 |
(34.5) |
(100.0) |
Source: Bloomberg, Thomson Reuters. Note: *Reporting currency. Priced at 17 September 2018.
We see significant synergistic and cross-selling advantages in the combination of the consulting and product portfolio. As a result, we believe there is a strong case for mVise to trade at a premium to the consulting sector because of its exposure to the higher multiple software product industry. To this we would also add its superior EBITDA margins (see comparison in Exhibit 2), which give greater earnings security.
At present, looking at prospective FY1 EV/EBITDA multiples mVise trades broadly in line with Adesso and Capgemini, which are the higher margin, more profitable stocks in the consulting sector, and well below the multiples of the software product peers.
We see potential for stock upside on a 12-month view based on:
■
Expectation of mVise having above-average earnings growth based on current consensus expectations (as can be seen in the P/E multiple changes between FY1 and FY2).
■
Our expectations of increasing market recognition in the market of the orientation of mVise towards product sales over the next 12 months as sales ramp up at elastic.io and SalesSphere.
■
The potential influence of trade sale multiples on the sum-of-the parts valuation of the group. For example, in March of this year Salesforce agreed to acquire Mulesoft, an integration platform as a service (PaaS) operator, similar to elastic.io for $6.5bn. The sale valued Mulesoft on a high 22x trailing revenue multiple. While we believe this high multiple significantly derives from Mulesoft’s strong market position and early mover advantage, the implications for elastic.io’s contribution to the group valuation in future years would be significant even at much lower implied multiples.
Acarix’s H1 results show steady sales with eight systems and 800 disposable patches sold to June. These generated H1 revenues of SEK465k with gross profit of SEK349k, a 75% average margin. We now expect sales of just over SEK1m for the full year 2018 before hoped-for German reimbursement in 2019. A new commercial officer, Per Persson, has joined. We do not expect a US launch before 2022 and we assume a US trial starts in 2019. The indicative value remains SEK448m (SEK19.46/share). Additional clinical studies are ongoing.